Structure via PubChem · Public domain (PubChem)
CX614
Sign in to saveAlso known as BDP 37, CX 614, CX-614
CX-614 is an ampakine drug developed by Cortex Pharmaceuticals. It has been investigated for its effect on AMPA receptors.
Chemical data
- Formula
- C13H13NO4
- Molecular weight
- 247.25 g/mol
- IUPAC name
- 4,7,11-trioxa-16-azatetracyclo[8.7.0.03,8.012,16]heptadeca-1,3(8),9-trien-17-one
- SMILES
- C1CC2N(C1)C(=O)C3=CC4=C(C=C3O2)OCCO4
- InChIKey
- RQEPVMAYUINZRE-UHFFFAOYSA-N
- XLogP
- 1.5
- Polar surface area
- 48 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 247.084458
Show 3 more facts
- chemical formula
- C₁₃H₁₃NO₄
- Commons category
- CX614
- canonical SMILES
- C1CC2N(C1)C(=O)C3=CC4=C(C=C3O2)OCCO4
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
CX-614 is an ampakine drug developed by Cortex Pharmaceuticals. It has been investigated for its effect on AMPA receptors.
Chronic CX-614 treatments produce rapid increases in the synthesis of the brain-derived neurotrophic factor BDNF which has very important effects on synaptic plasticity and may have applications in the treatment of neurodegenerative diseases such as Alzheimer's disease.
Excerpted from Wikipedia’s “CX614” article, available under the CC BY-SA 4.0 licence.